Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 422

1.

Why are eligible thrombolysis candidates left untreated?

Hills NK, Johnston SC.

Am J Prev Med. 2006 Dec;31(6 Suppl 2):S210-6. Epub 2006 Nov 7.

PMID:
17178305
2.

Prioritizing interventions to improve rates of thrombolysis for ischemic stroke.

California Acute Stroke Pilot Registry (CASPR) Investigators..

Neurology. 2005 Feb 22;64(4):654-9.

PMID:
15728287
3.

The use and misuse of thrombolytic therapy within the Veterans Health Administration.

Keyhani S, Arling G, Williams LS, Ross JS, Ordin DL, Myers J, Tyndall G, Vogel B, Bravata DM.

Med Care. 2012 Jan;50(1):66-73. doi: 10.1097/MLR.0b013e3182294092.

PMID:
22182924
4.

The use of intravenous recombinant tissue plasminogen activator in acute ischemic stroke.

Kahn JH, Viereck J, Kase C, Jeerakathil T, Romero R, Mehta SD, Kociol R, Babikian V.

J Emerg Med. 2005 Oct;29(3):273-7.

PMID:
16183445
5.

Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility.

Barber PA, Zhang J, Demchuk AM, Hill MD, Buchan AM.

Neurology. 2001 Apr 24;56(8):1015-20.

PMID:
11320171
6.

Utilization of intravenous tissue plasminogen activator for acute ischemic stroke.

Katzan IL, Hammer MD, Hixson ED, Furlan AJ, Abou-Chebl A, Nadzam DM; Cleveland Clinic Health System Stroke Quality Improvement Team..

Arch Neurol. 2004 Mar;61(3):346-50.

PMID:
15023810
7.

Acute stroke management in the elderly.

Zeevi N, Chhabra J, Silverman IE, Lee NS, McCullough LD.

Cerebrovasc Dis. 2007;23(4):304-8. Epub 2006 Dec 29.

PMID:
17199089
8.

The yield of expanding the therapeutic time window for tPA.

Owe JF, Sanaker PS, Naess H, Thomassen L.

Acta Neurol Scand. 2006 Nov;114(5):354-7.

PMID:
17022786
9.

Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry.

Tekle WG, Chaudhry SA, Hassan AE, Peacock JM, Lakshminarayan K, Tsai A, Luepker R, Anderson DC, Qureshi AI.

Cerebrovasc Dis. 2012;34(5-6):400-5. doi: 10.1159/000343504. Epub 2012 Dec 4.

PMID:
23221276
10.

Obstacles to the use of intravenous tissue plasminogen activator for acute ischemic stroke. Is time the only barrier?

Laloux P, Thijs V, Peeters A, Desfontaines P.

Acta Neurol Belg. 2007 Dec;107(4):103-7.

PMID:
18416282
11.

Time to hospital arrival, use of thrombolytics, and in-hospital outcomes in ischemic stroke.

Qureshi AI, Kirmani JF, Sayed MA, Safdar A, Ahmed S, Ferguson R, Hershey LA, Qazi KJ; Buffalo Metropolitan Area and Erie County Stroke Study Group..

Neurology. 2005 Jun 28;64(12):2115-20.

PMID:
15985583
12.

Thrombolysis candidates for the treatment of stroke at an emergency department in Japan.

Yamaguchi K, Hori S, Nogawa S, Tanahashi N, Fukuuchi Y, Aikawa N.

Acad Emerg Med. 2002 Jul;9(7):754-8.

13.
14.

Improved time intervals by implementation of computerized physician order entry-based stroke team approach.

Nam HS, Han SW, Ahn SH, Lee JY, Choi HY, Park IC, Heo JH.

Cerebrovasc Dis. 2007;23(4):289-93. Epub 2006 Dec 29.

PMID:
17199086
15.

Acute stroke thrombolysis with intravenous tissue plasminogen activator in an Australian tertiary hospital.

Szoeke CE, Parsons MW, Butcher KS, Baird TA, Mitchell PJ, Fox SE, Davis SM.

Med J Aust. 2003 Apr 7;178(7):324-8.

PMID:
12670274
16.

Utilization of intravenous tissue plasminogen activator for ischemic stroke: are there sex differences?

Allen NB, Myers D, Watanabe E, Dostal J, Sama D, Goldstein LB, Lichtman JH.

Cerebrovasc Dis. 2009;27(3):254-8. doi: 10.1159/000196824. Epub 2009 Jan 29.

PMID:
19176959
17.

IV tissue plasminogen activator use in acute stroke: experience from a statewide registry.

Deng YZ, Reeves MJ, Jacobs BS, Birbeck GL, Kothari RU, Hickenbottom SL, Mullard AJ, Wehner S, Maddox K, Majid A; Paul Coverdell National Acute Stroke Registry Michigan Prototype Investigators..

Neurology. 2006 Feb 14;66(3):306-12.

PMID:
16476927
18.

Influence of direct admission to Comprehensive Stroke Centers on the outcome of acute stroke patients treated with intravenous thrombolysis.

Pérez de la Ossa N, Millán M, Arenillas JF, Sánchez-Ojanguren J, Palomeras E, Dorado L, Guerrero C, Dávalos A.

J Neurol. 2009 Aug;256(8):1270-6. doi: 10.1007/s00415-009-5113-7. Epub 2009 Apr 8.

PMID:
19353224
19.

Reasons for exclusion from thrombolytic therapy following acute ischemic stroke.

Cocho D, Belvís R, Martí-Fàbregas J, Molina-Porcel L, Díaz-Manera J, Aleu A, Pagonabarraga J, García-Bargo D, Mauri A, Martí-Vilalta JL.

Neurology. 2005 Feb 22;64(4):719-20.

PMID:
15728300
20.

Reducing in-hospital delay to 20 minutes in stroke thrombolysis.

Meretoja A, Strbian D, Mustanoja S, Tatlisumak T, Lindsberg PJ, Kaste M.

Neurology. 2012 Jul 24;79(4):306-13. doi: 10.1212/WNL.0b013e31825d6011. Epub 2012 May 23.

PMID:
22622858

Supplemental Content

Support Center